Aged care shares take a hit amid Australian government inquiry into industry

Australia’s leading aged-care providers’ shares have plummeted, after Prime Minister Scott Morrison announced a government inquiry investigating the aged-care industry.

Source: Bloomberg

Mr Morrison announced the inquiry on Sunday, upon what he described as ‘’alarming and disturbing’’ spikes in elder abuse.

Leading providers lost as much as $318 million in market value on Monday after the announcement. Japara Healthcare Ltd stocks dropped 21%, Estia Health Ltd fell 17% and Regis Healthcare Ltd tumbled 20% upon the news.

Fisher & Paykel Healthcare Corporation Ltd also fell 1.3% while Ryman Healthcare Ltd dropped 0.4 %. The wider health care index was down 0.9 %.

The inquiry into the aged-care industry will investigate quality of care in residential facilities to elderly Australians and people with disabilities. This comes after Mr Morrison said the government had discovered malpractice in the industry including abuse and poor quality of care.

Annual government spending on aged care is expected to rise to $23 billion by 2023. According to GEN aged care data, government spending on aged care services has progressively increased each year since 2011-12.

In 2016 – 2017, governments spent an estimated $17 billion on aged care, with 69% towards residential aged care.

The call to action comes after authorities say they’ve shut at least one aged care facility a month since the Oakden nursing home scandal in April 2017.

This information has been prepared by IG, a trading name of IG Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.  Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. 

CFDs are a leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your initial deposit, so please ensure that you fully understand the risks involved.

Find articles by writer

All trading involves risk and losses can exceed deposits. Trading CFDs may not be suitable for everyone so please ensure that you fully understand the risks involved. All trading involves risk and losses can exceed deposits.